SAMJIN PHARMACEUTICAL CO.,LTD Logo

SAMJIN PHARMACEUTICAL CO.,LTD

Researches, develops, manufactures, and sells OTC and prescription medicines.

005500 | KO

Overview

Corporate Details

ISIN(s):
KR7005500004
LEI:
Country:
South Korea
Address:
서울특별시 마포구 와우산로 121 삼진제약사옥, 마포구

Description

Samjin Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes a wide range of over-the-counter (OTC) and prescription drugs, offered in various formulations such as oral, drop, and injectable forms. Notable products include the analgesic Gevorin, the antiplatelet agent Plavix, and the hypercholesterolemia treatment Newstatin-R. A central part of its strategy is a strong commitment to R&D, focusing on creating innovative new drugs to address diseases with high unmet medical needs. The company actively develops novel therapeutics for severe conditions, including cardiovascular, respiratory, and gastrointestinal diseases, with the goal of becoming a global pharmaceutical innovator.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 45.2 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 44.7 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 44.7 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 46.4 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 44.6 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 49.8 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 44.7 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 44.7 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 44.7 KB
2023-12-06 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 44.6 KB
2023-11-14 00:00
분기보고서 (2023.09)
Korean 1.0 MB
2023-11-07 00:00
최대주주등소유주식변동신고서
Korean 26.9 KB
2023-11-07 00:00
주식등의대량보유상황보고서(약식)
Korean 60.2 KB
2023-11-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2023-10-30 00:00
주식등의대량보유상황보고서(일반)
Korean 84.1 KB

Automate Your Workflow. Get a real-time feed of all SAMJIN PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAMJIN PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAMJIN PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.